Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
Gespeichert in:
| Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2010-09, Vol.59 (9), p.2087-2093 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2093 |
|---|---|
| container_issue | 9 |
| container_start_page | 2087 |
| container_title | Diabetes (New York, N.Y.) |
| container_volume | 59 |
| creator | PEAKMAN, Mark VON HERRATH, Matthias |
| description | |
| doi_str_mv | 10.2337/db10-0630 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2927927</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A237358002</galeid><sourcerecordid>A237358002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c674t-199a142c1b49a5da0b4ae597a86c2c0000bdf1e2593f88100d379669130f7a03</originalsourceid><addsrcrecordid>eNp9klGL1DAQx4so3nr64BeQooj40HOStE3jg7Cseh6snOA--BbSdNrL0Ta1aeXWT-8st56uLDIhgeQ3_5nMTBQ9ZXDGhZBvqpJBArmAe9GCKaESweW3-9ECgPGESSVPokchXANATvYwOuFQQCYKvojWy35yDfbJ1wGtq52NL7pu7v10haMZtnHtx3izHTBm8XtnSpwwvI0_mxvXuZ-ub2Li4i9-QlIx7ePoQW3agE_252m0-fhhs_qUrC_PL1bLdWJzmU4JU8qwlFtWpspklYEyNZgpaYrccktZQlnVDHmmRF0UDKASUuW5YgJqaUCcRu9uZYe57LCyFHw0rR5G15lxq71x-vCld1e68T80V1zSIoFXe4HRf58xTLpzwWLbmh79HLRMFbCMNiKf_0Ne-3ns6XNaZhnVMC920ItbqDEtatfXnqLanaReciFFVgBwopIjFJWeCt36HmtH1wf82RGerMLO2aMOrw8ciJnwZmrMHIIuztf_S2bPWt-22KCmbq0uj2rb0YcwYn1XbQZ6N4N6N4N6N4PEPvu7PXfk76Ej4OUeMMGath5Nb134wwme8jxLxS-sHt5f</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755053680</pqid></control><display><type>article</type><title>Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>PEAKMAN, Mark ; VON HERRATH, Matthias</creator><creatorcontrib>PEAKMAN, Mark ; VON HERRATH, Matthias</creatorcontrib><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db10-0630</identifier><identifier>PMID: 20805382</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Antigens ; Antigens - immunology ; Antigens - therapeutic use ; Autoantigens ; Autoimmune Diseases - immunology ; Biological and medical sciences ; Biomarkers ; Biomedical Research ; Clinical Trials as Topic ; Cytokines ; Dendritic Cells - immunology ; Development and progression ; Diabetes ; Diabetes Mellitus, Type 1 - immunology ; Diabetes Mellitus, Type 1 - pathology ; Diabetes. Impaired glucose tolerance ; Disease ; Drug therapy ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Epitopes - immunology ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Health aspects ; Humans ; Immunotherapy ; Immunotherapy - methods ; Insulin ; Insulin-Secreting Cells - pathology ; Lymphatic system ; Medical sciences ; Peptides ; Regulation ; s in Diabetes ; Type 1 diabetes</subject><ispartof>Diabetes (New York, N.Y.), 2010-09, Vol.59 (9), p.2087-2093</ispartof><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2010 American Diabetes Association</rights><rights>COPYRIGHT 2010 American Diabetes Association</rights><rights>Copyright American Diabetes Association Sep 2010</rights><rights>2010 by the American Diabetes Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c674t-199a142c1b49a5da0b4ae597a86c2c0000bdf1e2593f88100d379669130f7a03</citedby><cites>FETCH-LOGICAL-c674t-199a142c1b49a5da0b4ae597a86c2c0000bdf1e2593f88100d379669130f7a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927927/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927927/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23242654$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20805382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PEAKMAN, Mark</creatorcontrib><creatorcontrib>VON HERRATH, Matthias</creatorcontrib><title>Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><subject>Antigens</subject><subject>Antigens - immunology</subject><subject>Antigens - therapeutic use</subject><subject>Autoantigens</subject><subject>Autoimmune Diseases - immunology</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Biomedical Research</subject><subject>Clinical Trials as Topic</subject><subject>Cytokines</subject><subject>Dendritic Cells - immunology</subject><subject>Development and progression</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 1 - immunology</subject><subject>Diabetes Mellitus, Type 1 - pathology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Disease</subject><subject>Drug therapy</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Epitopes - immunology</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Immunotherapy - methods</subject><subject>Insulin</subject><subject>Insulin-Secreting Cells - pathology</subject><subject>Lymphatic system</subject><subject>Medical sciences</subject><subject>Peptides</subject><subject>Regulation</subject><subject>s in Diabetes</subject><subject>Type 1 diabetes</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9klGL1DAQx4so3nr64BeQooj40HOStE3jg7Cseh6snOA--BbSdNrL0Ta1aeXWT-8st56uLDIhgeQ3_5nMTBQ9ZXDGhZBvqpJBArmAe9GCKaESweW3-9ECgPGESSVPokchXANATvYwOuFQQCYKvojWy35yDfbJ1wGtq52NL7pu7v10haMZtnHtx3izHTBm8XtnSpwwvI0_mxvXuZ-ub2Li4i9-QlIx7ePoQW3agE_252m0-fhhs_qUrC_PL1bLdWJzmU4JU8qwlFtWpspklYEyNZgpaYrccktZQlnVDHmmRF0UDKASUuW5YgJqaUCcRu9uZYe57LCyFHw0rR5G15lxq71x-vCld1e68T80V1zSIoFXe4HRf58xTLpzwWLbmh79HLRMFbCMNiKf_0Ne-3ns6XNaZhnVMC920ItbqDEtatfXnqLanaReciFFVgBwopIjFJWeCt36HmtH1wf82RGerMLO2aMOrw8ciJnwZmrMHIIuztf_S2bPWt-22KCmbq0uj2rb0YcwYn1XbQZ6N4N6N4N6N4PEPvu7PXfk76Ej4OUeMMGath5Nb134wwme8jxLxS-sHt5f</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>PEAKMAN, Mark</creator><creator>VON HERRATH, Matthias</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100901</creationdate><title>Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential</title><author>PEAKMAN, Mark ; VON HERRATH, Matthias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c674t-199a142c1b49a5da0b4ae597a86c2c0000bdf1e2593f88100d379669130f7a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antigens</topic><topic>Antigens - immunology</topic><topic>Antigens - therapeutic use</topic><topic>Autoantigens</topic><topic>Autoimmune Diseases - immunology</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Biomedical Research</topic><topic>Clinical Trials as Topic</topic><topic>Cytokines</topic><topic>Dendritic Cells - immunology</topic><topic>Development and progression</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 1 - immunology</topic><topic>Diabetes Mellitus, Type 1 - pathology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Disease</topic><topic>Drug therapy</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Epitopes - immunology</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Immunotherapy - methods</topic><topic>Insulin</topic><topic>Insulin-Secreting Cells - pathology</topic><topic>Lymphatic system</topic><topic>Medical sciences</topic><topic>Peptides</topic><topic>Regulation</topic><topic>s in Diabetes</topic><topic>Type 1 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PEAKMAN, Mark</creatorcontrib><creatorcontrib>VON HERRATH, Matthias</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PEAKMAN, Mark</au><au>VON HERRATH, Matthias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>59</volume><issue>9</issue><spage>2087</spage><epage>2093</epage><pages>2087-2093</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>20805382</pmid><doi>10.2337/db10-0630</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-1797 |
| ispartof | Diabetes (New York, N.Y.), 2010-09, Vol.59 (9), p.2087-2093 |
| issn | 0012-1797 1939-327X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2927927 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Antigens Antigens - immunology Antigens - therapeutic use Autoantigens Autoimmune Diseases - immunology Biological and medical sciences Biomarkers Biomedical Research Clinical Trials as Topic Cytokines Dendritic Cells - immunology Development and progression Diabetes Diabetes Mellitus, Type 1 - immunology Diabetes Mellitus, Type 1 - pathology Diabetes. Impaired glucose tolerance Disease Drug therapy Endocrine pancreas. Apud cells (diseases) Endocrinopathies Epitopes - immunology Etiopathogenesis. Screening. Investigations. Target tissue resistance Health aspects Humans Immunotherapy Immunotherapy - methods Insulin Insulin-Secreting Cells - pathology Lymphatic system Medical sciences Peptides Regulation s in Diabetes Type 1 diabetes |
| title | Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T04%3A27%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antigen-Specific%20Immunotherapy%20for%20Type%201%20Diabetes:%20Maximizing%20the%20Potential&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=PEAKMAN,%20Mark&rft.date=2010-09-01&rft.volume=59&rft.issue=9&rft.spage=2087&rft.epage=2093&rft.pages=2087-2093&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/db10-0630&rft_dat=%3Cgale_pubme%3EA237358002%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=755053680&rft_id=info:pmid/20805382&rft_galeid=A237358002&rfr_iscdi=true |